“…Estimated glomerular filtration rate (eGFR) declines prior to more severe macroalbuminuria in type 2 diabetes (T2D); hence a combination of eGFR and albuminuria can be used to stage and monitor patients (American Diabetes Association, 2013; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013). While diabetes is the major cause of renal disease in patients with diabetes, in about a third of patients, renal dysfunction is due to other causes (non-diabetic renal disease; NDRD) (Chong, Keng, Tan, et al, 2012;Das, Dakshinamurty, Prayaga, & Uppin, 2012;Harada, Akai, Sumida, et al, 2013;Kleinknecht, Bennis, & Altman, 1992;Lee, Chung, & Choi, 1999;Mazzucco, Bertani, Fortunato, et al, 2002;Olsen & Mogensen, 1996;Richards et al, 1992;Soni, Gowrishankar, Kishan, & Raman, 2006;Yaqub, Kashif, & Hussain, 2012). In the NDRD group, the treatment of renal disease may require a different strategy.…”